Protocol No.: GB27862; "A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Uncontrolled Asthma Who are on Inhaled Corticosteriods and a Second Controller Medication"

Project: Other project

StatusFinished
Effective start/end date5/16/125/15/14

Funding

  • Genentech, Inc.: $7,500.00